ATE233243T1 - Salze von chinolinderivaten als nk3 antagonisten - Google Patents
Salze von chinolinderivaten als nk3 antagonistenInfo
- Publication number
- ATE233243T1 ATE233243T1 AT96941026T AT96941026T ATE233243T1 AT E233243 T1 ATE233243 T1 AT E233243T1 AT 96941026 T AT96941026 T AT 96941026T AT 96941026 T AT96941026 T AT 96941026T AT E233243 T1 ATE233243 T1 AT E233243T1
- Authority
- AT
- Austria
- Prior art keywords
- antagonists
- salts
- quinoline derivatives
- quinoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9524137.8A GB9524137D0 (en) | 1995-11-24 | 1995-11-24 | Novel compounds |
PCT/EP1996/005210 WO1997019928A1 (en) | 1995-11-24 | 1996-11-22 | Salts of quinoline derivatives as nk3 antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE233243T1 true ATE233243T1 (de) | 2003-03-15 |
Family
ID=10784449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96941026T ATE233243T1 (de) | 1995-11-24 | 1996-11-22 | Salze von chinolinderivaten als nk3 antagonisten |
Country Status (23)
Country | Link |
---|---|
US (3) | US6355654B1 (de) |
EP (1) | EP0876348B1 (de) |
JP (1) | JP4377454B2 (de) |
KR (1) | KR19990071599A (de) |
CN (1) | CN1207728A (de) |
AR (1) | AR004970A1 (de) |
AT (1) | ATE233243T1 (de) |
AU (1) | AU722451B2 (de) |
BR (1) | BR9611729A (de) |
CA (1) | CA2238312A1 (de) |
CZ (1) | CZ158198A3 (de) |
DE (1) | DE69626416T2 (de) |
ES (1) | ES2192621T3 (de) |
GB (1) | GB9524137D0 (de) |
HU (1) | HUP9903584A3 (de) |
IL (1) | IL124352A0 (de) |
MX (1) | MX9804106A (de) |
NO (1) | NO310866B1 (de) |
NZ (1) | NZ323389A (de) |
PL (1) | PL326927A1 (de) |
TR (1) | TR199800925T2 (de) |
WO (1) | WO1997019928A1 (de) |
ZA (1) | ZA969812B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9825554D0 (en) * | 1998-11-20 | 1999-01-13 | Smithkline Beecham Spa | Novel Compounds |
US7037922B1 (en) | 2000-03-10 | 2006-05-02 | Neurogen Corporation | Aryl fused 2,4-disubstituted pyridines: NK3 receptor ligands |
US6413982B1 (en) | 1999-03-29 | 2002-07-02 | Neurogen Corporation | 4-substituted quinoline derivatives |
AU4802500A (en) | 1999-04-26 | 2000-11-10 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
US20080200500A1 (en) * | 2005-06-03 | 2008-08-21 | Astrazeneca Ab | Quinoline Derivatives as Nk3 Antagonists |
GB0515580D0 (en) | 2005-07-29 | 2005-09-07 | Merck Sharp & Dohme | Therapeutic compounds |
EP1919871A4 (de) * | 2005-08-02 | 2010-08-18 | Glaxosmithkline Llc | Verfahren zur synthese von chinolinderivaten |
EP1915363A1 (de) * | 2005-08-11 | 2008-04-30 | AstraZeneca AB | Oxopyridylchinolinamide als modulatoren des nk3-rezeptors |
AR057130A1 (es) * | 2005-09-21 | 2007-11-14 | Astrazeneca Ab | Quinolinas de alquilsulfoxido y una composicion farmaceutica |
CN101268052A (zh) * | 2005-09-21 | 2008-09-17 | 阿斯利康(瑞典)有限公司 | 作为nk-3受体配体的n-氧代-杂环和n-氧代-烷基喹啉-4-甲酰胺 |
TW201018662A (en) | 2005-12-12 | 2010-05-16 | Astrazeneca Ab | Alkylsulphonamide quinolines |
JP2009524656A (ja) * | 2006-01-27 | 2009-07-02 | アストラゼネカ・アクチエボラーグ | アミド置換キノリン |
FR2979173B1 (fr) * | 2011-08-19 | 2013-08-16 | St Microelectronics Grenoble 2 | Commutateur analogique basse tension |
EP2775841B1 (de) * | 2011-11-03 | 2017-09-13 | Merck Sharp & Dohme Corp. | Chinolincarboxamid- und chinolincarbonitrilderivate als mglur2-negative allosterische modulatoren, zusammensetzungen und ihre verwendung |
US9475773B2 (en) | 2013-04-19 | 2016-10-25 | Astrazeneca Ab | NK3 receptor antagonist compound (NK3RA) for use in a method for the treatment of polycystic ovary syndrome (PCOS) |
WO2017072629A1 (en) | 2015-10-29 | 2017-05-04 | Cadila Healthcare Limited | Pharmaceutical combination of nk3 receptor antagonist and biguanides |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3664492B2 (ja) * | 1994-05-27 | 2005-06-29 | スミスクライン・ビーチャム・ファーマシューティチ・ソシエタ・ペル・アチオニ | タチキニン nk▲下3▼ 受容体アンタゴニストとしてのキノリン誘導体 |
IT1270615B (it) * | 1994-07-14 | 1997-05-07 | Smithkline Beecham Farma | Uso di derivati di chinolina |
-
1995
- 1995-11-24 GB GBGB9524137.8A patent/GB9524137D0/en active Pending
-
1996
- 1996-11-21 AR ARP960105281A patent/AR004970A1/es unknown
- 1996-11-22 HU HU9903584A patent/HUP9903584A3/hu unknown
- 1996-11-22 EP EP96941026A patent/EP0876348B1/de not_active Expired - Lifetime
- 1996-11-22 DE DE69626416T patent/DE69626416T2/de not_active Expired - Lifetime
- 1996-11-22 US US09/077,152 patent/US6355654B1/en not_active Expired - Fee Related
- 1996-11-22 ES ES96941026T patent/ES2192621T3/es not_active Expired - Lifetime
- 1996-11-22 ZA ZA9609812A patent/ZA969812B/xx unknown
- 1996-11-22 PL PL96326927A patent/PL326927A1/xx unknown
- 1996-11-22 AT AT96941026T patent/ATE233243T1/de not_active IP Right Cessation
- 1996-11-22 BR BR9611729A patent/BR9611729A/pt unknown
- 1996-11-22 JP JP52016097A patent/JP4377454B2/ja not_active Expired - Fee Related
- 1996-11-22 IL IL12435296A patent/IL124352A0/xx unknown
- 1996-11-22 TR TR1998/00925T patent/TR199800925T2/xx unknown
- 1996-11-22 CN CN96199611A patent/CN1207728A/zh active Pending
- 1996-11-22 CZ CZ981581A patent/CZ158198A3/cs unknown
- 1996-11-22 AU AU10319/97A patent/AU722451B2/en not_active Ceased
- 1996-11-22 WO PCT/EP1996/005210 patent/WO1997019928A1/en not_active Application Discontinuation
- 1996-11-22 CA CA002238312A patent/CA2238312A1/en not_active Abandoned
- 1996-11-22 NZ NZ323389A patent/NZ323389A/en unknown
- 1996-11-22 KR KR1019980703875A patent/KR19990071599A/ko not_active Application Discontinuation
-
1998
- 1998-05-22 MX MX9804106A patent/MX9804106A/es unknown
- 1998-05-22 NO NO19982332A patent/NO310866B1/no not_active IP Right Cessation
-
2001
- 2001-11-06 US US09/994,076 patent/US6432977B1/en not_active Expired - Fee Related
-
2002
- 2002-06-12 US US10/167,881 patent/US20020156097A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0876348B1 (de) | 2003-02-26 |
CA2238312A1 (en) | 1997-06-05 |
AR004970A1 (es) | 1999-04-07 |
NO982332D0 (no) | 1998-05-22 |
AU722451B2 (en) | 2000-08-03 |
AU1031997A (en) | 1997-06-19 |
GB9524137D0 (en) | 1996-01-24 |
CZ158198A3 (cs) | 1998-10-14 |
CN1207728A (zh) | 1999-02-10 |
NZ323389A (en) | 2000-02-28 |
JP2000500770A (ja) | 2000-01-25 |
JP4377454B2 (ja) | 2009-12-02 |
US6355654B1 (en) | 2002-03-12 |
HUP9903584A2 (hu) | 2000-02-28 |
PL326927A1 (en) | 1998-11-09 |
US20020156097A1 (en) | 2002-10-24 |
US6432977B1 (en) | 2002-08-13 |
KR19990071599A (ko) | 1999-09-27 |
NO310866B1 (no) | 2001-09-10 |
ZA969812B (en) | 1998-05-22 |
ES2192621T3 (es) | 2003-10-16 |
TR199800925T2 (xx) | 2001-05-21 |
US20020077335A1 (en) | 2002-06-20 |
IL124352A0 (en) | 1998-12-06 |
MX9804106A (es) | 1998-09-30 |
DE69626416D1 (de) | 2003-04-03 |
WO1997019928A1 (en) | 1997-06-05 |
BR9611729A (pt) | 1999-04-06 |
EP0876348A1 (de) | 1998-11-11 |
DE69626416T2 (de) | 2003-12-24 |
NO982332L (no) | 1998-05-22 |
HUP9903584A3 (en) | 2001-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE246677T1 (de) | Chinolinderivate als tachykinin nk3 rezeptor antagonisten | |
DE69628334D1 (de) | Chinolin derivate als nk3 antagoniste | |
DE69304243D1 (de) | Chinolin-Verbindungen als Angiotensin-II-Antagoniste | |
DE69431604D1 (de) | Benzofuranderivate als tachykininantagonisten | |
DE69634416D1 (de) | Chinolin-derivate | |
ATE233243T1 (de) | Salze von chinolinderivaten als nk3 antagonisten | |
ATE187172T1 (de) | Chinolin-2-on derivate als serotonin antagonisten | |
ATE201199T1 (de) | Benzo(g)chinolinderivate | |
NO974605D0 (no) | Nye heterosykliske forbindelser | |
DE69617995D1 (de) | Indolalkylderivate von benzodioxanmenthylamin als 5-ht1a rezeptor liganden | |
FI962639A0 (fi) | Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina | |
NO930520D0 (no) | Bifenyl-substituerte kinolinderivater | |
ATE325118T1 (de) | Piperazinoderivate als neurokinin-antagonisten | |
BR9205939A (pt) | Derivados de 4-aril-3-(heteroalilureído)quinolina | |
DE69328701D1 (de) | Diazabicycloderivate als 5-HT3-Antagonisten | |
ATE208764T1 (de) | Isazole derivate als fibrinogen-rezeptor- antagonisten | |
NO981216D0 (no) | Nye heterosykliske forbindelser | |
NO993013D0 (no) | Nye heterosykliske substituerte pyrrolidinamidderivater | |
DE69621706D1 (de) | Verwendung von Piperazinverbindungen als narkotische Antagonisten | |
DK0940391T3 (da) | Quinolinderivater som tachykinin-NK3-receptor-antagonister |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |